Financial reports
Current reports
8-K
Entry into a Material Definitive Agreement
22 Mar 23
8-K
Submission of Matters to a Vote of Security Holders
16 Mar 23
8-K
Other Events
9 Mar 23
8-K
Entry into a Material Definitive Agreement
16 Feb 23
8-K
IsoPlexis Reports Preliminary Full Year 2022 Revenue
12 Jan 23
8-K
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
21 Dec 22
8-K
IsoPlexis Reports Third Quarter 2022 Financial Results
10 Nov 22
8-K
Regulation FD Disclosure
12 Sep 22
8-K
IsoPlexis Announces the Appointment of former Luminex
23 Aug 22
8-K
IsoPlexis Reports Second Quarter 2022 Financial Results
10 Aug 22
Registration and prospectus
15-12G
Securities registration termination
31 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 23
25-NSE
Exchange delisting
21 Mar 23
425
Business combination disclosure
16 Mar 23
425
Business combination disclosure
16 Mar 23
425
Business combination disclosure
9 Mar 23
425
Business combination disclosure
7 Mar 23
425
Business combination disclosure
6 Mar 23
425
Business combination disclosure
28 Feb 23
Other
SD
Conflict minerals disclosure
31 May 22
EFFECT
Notice of effectiveness
8 Oct 21
CERT
Certification of approval for exchange listing
7 Oct 21
SEC STAFF
SEC staff action: Order
7 Oct 21
CORRESP
Correspondence with SEC
5 Oct 21
CORRESP
Correspondence with SEC
5 Oct 21
SEC STAFF
SEC staff action: Order
30 Aug 21
CORRESP
Correspondence with SEC
20 Aug 21
SEC STAFF
SEC staff action: Order
2 Aug 21
UPLOAD
Letter from SEC
30 Jul 21